U.S. Stock News

NasdaqCM:RGTI
NasdaqCM:RGTISemiconductor

Is Rigetti Computing (RGTI) Pricing Reflect Its Quantum Roadmap After 120% One-Year Surge

If you are wondering whether Rigetti Computing's recent share price puts it above or below a reasonable value, you are not alone. This article is designed to help you frame that question clearly. Rigetti's stock closed at US$18.64, with a 17.1% return over the past week, a 15.3% decline over the past month, a 21.0% decline year to date, and a 120.3% return over the past year. These moves may leave you questioning whether the current price reflects opportunity or higher risk. Recent news...
NasdaqGS:STRL
NasdaqGS:STRLConstruction

Sterling Infrastructure (STRL) Margin Slippage And EPS Softening Test Bullish Growth Narratives

Sterling Infrastructure (STRL) has wrapped up FY 2025 with fourth quarter revenue of US$755.6 million and basic EPS of US$2.85, alongside net income of US$87.6 million, setting a clear marker for how the year finished. Over the past six quarters, the company has seen quarterly revenue move from US$498.8 million in Q4 2024 to US$755.6 million in Q4 2025, while basic EPS shifted from US$3.69 to US$2.85 and trailing twelve month EPS went from US$5.98 in Q3 2024 to US$9.50 in Q4 2025, giving...
NYSE:PERF
NYSE:PERFSoftware

Is Perfect (PERF) Quietly Reframing Its Moat Around B2B Beauty Personalization APIs?

Perfect Corp. recently announced a partnership with True Beauty Lashes to power LashLovr™, an AI-driven lash matching and virtual try-on experience that uses its Virtual Try-On and Face Analyzer APIs to help shoppers find better-fitting false lashes in real time. This collaboration highlights how Perfect’s pay-as-you-go AI and AR APIs can lower adoption hurdles for beauty brands while showcasing a concrete, research-backed use case that could support broader B2B uptake of its technology...
NasdaqGS:OS
NasdaqGS:OSSoftware

Assessing OneStream (OS) Valuation After Recent Share Price Momentum And DCF Signals

How OneStream (OS) Has Been Trading Recently With no single headline event driving OneStream (OS) today, investors are instead weighing its recent share performance, revenue profile, and current losses to assess how the stock fits into their software exposure. See our latest analysis for OneStream. At a recent share price of $23.60, OneStream sits on a 90 day share price return of 13.3% and a year to date share price return of 33.18%, while the 1 year total shareholder return is 3.1%. This...
NYSE:ACN
NYSE:ACNIT

US Stock Market Today S&P 500 Futures Ease As Housing And Factory Signals Diverge

The Morning Bull - US Market Morning Update Friday, Feb, 27 2026 US stock futures are pointing slightly lower this morning, with E-mini S&P 500 futures down about 0.2%, as investors weigh cheaper borrowing costs against mixed global growth signals. The 30 year US mortgage rate has dipped below 6% to 5.98%, which can make monthly payments a bit less painful and puts housing related names in focus. At the same time, the Kansas Fed Manufacturing Index has bounced to 10, a sign that factory...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

Soleno Therapeutics Q4 Profitability Milestone Tests High P/E Narrative

Soleno Therapeutics (SLNO) just closed out FY 2025 with fourth quarter revenue of US$91.7 million and basic EPS of US$0.81, alongside net income of US$42.9 million. This capped a trailing 12 month line that shows revenue of US$190.4 million and basic EPS of US$0.40. The company reported revenue of US$66.0 million in Q3 and US$32.7 million in Q2, while EPS moved from US$0.49 in Q3 and a small loss in Q2. Together, these figures describe a story where higher sales and a cleaner income line are...
NYSE:DCO
NYSE:DCOAerospace & Defense

Ducommun (DCO) Swings Back To Quarterly Profit But Trailing Loss Tests Bullish Narratives

Ducommun (DCO) has wrapped up FY 2025 with fourth quarter revenue of US$215.8 million and basic EPS of US$0.50, alongside net income of US$7.4 million. The trailing twelve month figures show revenue of US$824.7 million and a net loss of US$33.9 million tied to basic EPS of US$2.27. Over recent quarters, revenue has moved from US$197.3 million in Q4 2024 to US$215.8 million in Q4 2025, with quarterly basic EPS ranging from a loss of US$4.30 in Q3 2025 to a profit of US$0.50 in Q4 2025. For...
NYSE:MMI
NYSE:MMIReal Estate

How Investors Are Reacting To Marcus & Millichap (MMI) Q4 Profit, Full-Year Loss and Buyback Completion

In February 2026, Marcus & Millichap, Inc. reported fourth-quarter 2025 revenue of US$243.95 million and net income of US$13.31 million, alongside full-year 2025 revenue of US$755.16 million and a net loss of US$1.91 million, while also disclosing that it completed a share repurchase program totaling 3,146,936 shares for US$98.00 million. These results show improved quarterly profitability and a smaller full-year loss compared with the prior year, while the completed buyback reduced the...
NYSE:GIC
NYSE:GICTrade Distributors

Is It Time To Reassess Global Industrial (GIC) After Its Strong 1 Year Share Price Run

Are you wondering if Global Industrial still offers good value after its recent run, or if the current price already reflects the key positives for the business? The stock last closed at US$33.26, with returns of 4.3% over 7 days, 9.9% over 30 days, 13.1% year to date, 48.4% over 1 year, 32.6% over 3 years and 10.4% over 5 years. This naturally raises questions about what is now priced in. Recent coverage has focused on Global Industrial's role as a distributor of industrial and business...
NasdaqGM:AXSM
NasdaqGM:AXSMPharmaceuticals

Axsome Explores Solriamfetol In Phase 3 CLARITY Trial For MDD Subset

Axsome Therapeutics (NasdaqGM: AXSM) has started the CLARITY Phase 3 trial of solriamfetol in major depressive disorder with excessive daytime sleepiness. The trial focuses on a group of MDD patients who experience excessive daytime sleepiness, for which no approved treatments are currently available. This study expands Axsome's clinical program into an area of unmet medical need. Axsome Therapeutics, listed on the NasdaqGM under the ticker AXSM, develops therapies for central nervous...
NYSE:SPXC
NYSE:SPXCMachinery

SPX Technologies Reshapes Business With Deals Earnings And Shifting Ownership

SPX Technologies is pursuing an acquisition-led expansion and investing heavily in capacity, including in data center infrastructure. The company recently reported record earnings that align with this repositioning of its business mix. At the same time, insider selling and shifts in institutional ownership are reshaping who holds NYSE:SPXC shares. For investors, this mix of corporate activity and ownership changes makes NYSE:SPXC a stock to watch. The shares recently closed at $231.59, with...
NasdaqGS:PZZA
NasdaqGS:PZZAHospitality

Papa Johns International PZZA Margin Compression Reinforces Bearish Cost Narrative In FY 2025 Results

Papa John's International FY 2025 Earnings Snapshot Papa John's International (PZZA) closed out FY 2025 with Q4 revenue of US$498.2 million and basic EPS of US$0.24, while trailing twelve month revenue came in at about US$2.1 billion with EPS of US$0.93. The company has seen quarterly revenue move from US$530.8 million in Q4 2024 to US$498.2 million in Q4 2025, with basic EPS shifting from US$0.45 to US$0.24 over the same period, and trailing net income excluding extra items sitting at...
NYSE:JXN
NYSE:JXNDiversified Financial

Will Profit Squeeze Amid Record Annuity Sales and Heavy Buybacks Change Jackson Financial's (JXN) Narrative

In February 2026, Jackson Financial Inc. reported fourth-quarter 2025 revenue of US$1,988 million but swung to a net loss of US$204 million, while also increasing its common dividend, declaring a preferred dividend, and completing a large share repurchase program that retired just over 40% of its shares since 2021. Despite record retail annuity sales and continued capital returns, the sharp drop in yearly net income to US$27 million and a move from earnings per share to a loss per share have...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Ultragenyx Priority Review For DTX401 Spurs Fresh Look At Valuation

Ultragenyx Pharmaceutical (NasdaqGS:RARE) announced that the US FDA has accepted its Biologics License Application for DTX401, a gene therapy for Glycogen Storage Disease Type Ia. The FDA has granted Priority Review to the application, signaling an expedited assessment timeline. If approved, DTX401 could become the first pharmacologic treatment option for people living with Glycogen Storage Disease Type Ia. For Ultragenyx, with a current share price of $23.04, this regulatory milestone...
NasdaqGS:IDXX
NasdaqGS:IDXXMedical Equipment

Idexx Board Changes Prompt Fresh Look At Growth Valuation And Risk

IDEXX Laboratories (NasdaqGS:IDXX) announced the upcoming retirement of long-serving Board member M. Anne Szostak. The company also disclosed the appointment of Michael G. Erickson, PhD, to its Board of Directors. These Board changes reflect an ongoing refresh of corporate governance and Board composition. IDEXX Laboratories focuses on diagnostic and software solutions for veterinary practices, livestock, poultry, and water testing, placing the company at the center of long term trends in...
NYSE:ASPN
NYSE:ASPNChemicals

Why Aspen Aerogels (ASPN) Is Down 13.3% After Impairment-Driven Loss And Strategic Review News

In February 2026, Aspen Aerogels reported fourth-quarter 2025 sales of US$41.34 million versus US$123.09 million a year earlier, swung to a net loss of US$72.91 million, recorded an impairment charge on property, plant and equipment, and launched a broad review of options for its business and capital structure. An important insight is that management characterizes this strategic review as coming from a position of financial strength and operational progress, even as the company posts a...
NYSEAM:CET
NYSEAM:CETCapital Markets

Did Central Securities' (CET) 2025 Net Income Reveal a Shift in Its Investment Narrative?

Central Securities Corporation (NYSE American: CET) has released its annual report for the year ended December 31, 2025, reporting full-year net income of US$265.21 million. The annual report gives investors a clearer view into how this closed-end investment company managed its portfolio and operations over the 2025 calendar year. We will now examine how Central Securities’ 2025 net income performance shapes the company’s investment narrative for shareholders and prospective...
NasdaqGS:NVDA
NasdaqGS:NVDASemiconductor

Nvidia (NVDA) Margins Near 56% Reinforce Bullish AI Narrative Despite Cash Quality Doubts

Nvidia (NVDA) has put up big headline numbers for FY 2026, with fourth quarter revenue of about US$68.1b and basic EPS of US$1.77, capping a year in which trailing 12 month EPS reached US$4.93 alongside revenue of roughly US$215.9b. Over the past six quarters, the company has seen quarterly revenue move from about US$35.1b with EPS of US$0.79 in FY 2025 Q3 to US$68.1b and EPS of US$1.77 in FY 2026 Q4. This sets up a story where investors are watching how rich margins and strong earnings...
NasdaqCM:PLUG
NasdaqCM:PLUGElectrical

Is Plug Power (PLUG) Now Attractive After Recent Share Price Weakness?

Wondering whether Plug Power's share price around US$1.91 is starting to look like value, or if it still carries more risk than upside? You are not alone in asking that question right now. The stock has been flat over the last 7 days, while the 30 day return is a 20.7% decline, set against a 17.2% gain over 1 year and much weaker 3 and 5 year returns of 85.7% and 95.2% declines. Recent news flow has focused on Plug Power's position in hydrogen and fuel cell markets, as investors weigh long...
NasdaqGS:GTX
NasdaqGS:GTXAuto Components

Garrett Motion Cling Deal Links EV HVAC Growth To Turbocharger Future

Garrett Motion (NasdaqGS:GTX) agreed to supply its oil free centrifugal compressor to Cling for use in China's next generation electric buses and trucks. The deal represents Garrett Motion's first serial award for its oil free, foil bearing based centrifugal compressor within the mobility sector. The compressor is intended to support advanced HVAC systems that focus on energy efficiency, compact size, reduced noise, and durability for commercial EVs in China. Garrett Motion, best known for...
NasdaqGS:SSP
NasdaqGS:SSPMedia

Scripps (SSP) TTM Loss Of US$164 Million Challenges Bullish Earnings Recovery Narratives

E.W. Scripps (SSP) has just wrapped up FY 2025 with fourth quarter revenue of US$560.3 million, basic EPS of US$0.51 loss, and net income excluding extra items of US$44.9 million loss, while trailing twelve month revenue came in at about US$2.2 billion with basic EPS of US$1.87 loss. Over recent quarters, the company has seen revenue move from US$728.4 million and basic EPS of US$0.93 in Q4 2024 to US$560.3 million and basic EPS of US$0.51 loss in Q4 2025, with net income shifting from...
NasdaqGS:SBCF
NasdaqGS:SBCFBanks

Is Seacoast Banking Corporation of Florida (SBCF) Pricing Reflecting Its Mixed Valuation Signals?

If you are wondering whether Seacoast Banking Corporation of Florida is currently priced attractively, you are not alone. The stock has drawn interest from investors trying to work out if today’s share price lines up with its fundamentals. Over the past year, the share price return sits at 21.0%, with a 4.1% gain year to date. This comes even though the last 7 and 30 days have seen modest pullbacks of 1.8% and 2.2% respectively from the recent close at US$32.90. Recent coverage of regional...
NasdaqGS:TCBK
NasdaqGS:TCBKBanks

Is It Time To Reconsider TriCo Bancshares (TCBK) After Its Recent Share Price Performance?

If you are wondering whether TriCo Bancshares is fairly priced or offering value at its recent levels, this article will walk you through what the numbers actually say about the stock. The share price last closed at US$49.77, with returns of a 0.9% decline over 7 days, 1.4% over 30 days, 5.6% year to date, 18.6% over 1 year and 26.7% over 5 years. This naturally raises questions about how much is already reflected in the price and how much risk is being priced in. Recent coverage of TriCo...
NasdaqGS:URBN
NasdaqGS:URBNSpecialty Retail

Urban Outfitters (URBN) Margin Stability At 7.5% Tests Bullish Profit Growth Narratives

Urban Outfitters FY 2026 results: steady revenue and earnings backdrop Urban Outfitters (URBN) has just wrapped up FY 2026 with fourth quarter revenue of US$1.8 billion, basic EPS of US$1.07 and net income of US$96.3 million, setting the tone for how investors will read the full year. The company has seen quarterly revenue move from US$1.53 billion in Q3 FY 2026 to US$1.8 billion in Q4, while basic EPS shifted from US$1.30 to US$1.07 over the same stretch, and trailing twelve month EPS...